Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating MV-NIS infected mesenchymal stem cells for recurrent ovarian, primary peritoneal, or fallopian tube cancer. Res…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer [Phase 1]
Phase 1 bioequivalence study evaluating pharmacokinetics and safety of BR2022 and BR2022-1 in patients with deleterious BRCA-mutated advance…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Evaluating the Efficacy of Hyperthermic Intraperitoneal Treatment to Enhance the Sensitivity of Immune Checkpoint Inhibitor in Patients With Advanced Ovarian Cancer： A Single-arm Study [Phase 2]
Phase 2 single-arm trial evaluating whether hyperthermic intraperitoneal chemotherapy (HIPEC) can enhance the efficacy of immune checkpoint …
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: ICRA Randomised Controlled Trial [Phase 3]
A Phase 3 randomized controlled trial (ICRA) investigating treatment for ovarian cancer is listed (NCT07068464), sponsored by NHS Grampian, …
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating sequential CD146 and GPC3 CAR-T cell therapy for advanced ovarian cancer and is currently recruitin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C) [Phase 2]
A Phase 2 neoadjuvant trial (COHORT-C) comparing niraparib to platinum-taxane chemotherapy in homologous recombination–deficient advanced ov…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer [Phase 2]
Phase 2 study evaluating the efficacy and safety of novel treatment combinations in participants with ovarian cancer has completed, and resu…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
This clinical trial update reports long-term follow-up of participants treated with A2 Biotherapeutics' gene therapy products in solid tumor…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies [Phase 1, Phase 2]
SPEDOX-6, a single protein encapsulated doxorubicin, is being studied in Phase 1/2 trials for several advanced cancers and is currently recr…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of focused ultrasound ablation with PD-1 antibody blockade in advanced solid tumors has been termin…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of INCB106385, alone or with immunotherapy, in advanced solid tumors has completed. The study includes multiple indications …
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations [Phase 2]
A Phase 2 trial evaluating Copanlisib in combination with Fulvestrant in ER+/PR+ cancers with PI3K/PTEN alterations was terminated, with tri…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Design and Validation of Plasma Proteins and Cytokine Panels to Identify Markers Associated With Response to Niraparib as Maintenance Treatment After First-line Platinum-based Regimen in Patients With Advanced Ovarian Cancer
A protocol-level study to design and validate plasma protein and cytokine panels to identify biomarkers associated with response to Nirapari…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression [Phase 2]
Phase 2 clinical trial investigating perioperative inhibition of beta-adrenergic and COX-2 signaling to reduce progression of ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy [Phase 3]
A Phase 3 trial evaluating olaparib as maintenance monotherapy in relapsed ovarian cancer after a complete or partial response to platinum c…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Prehabilitation in Ovarian Cancer Patients During Chemiotherapy Before Cytoreductive Surgery. [NA]
Ongoing clinical trial update shows enrollment is open for a prehabilitation program in ovarian cancer patients undergoing chemotherapy befo…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: RC48 in Combination With AK104 and Bevacizumab in OCCC [Phase 2]
Phase 2 clinical trial evaluating RC48 in combination with AK104 and bevacizumab for ovarian cancer, including ovarian clear cell carcinoma,…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients [Phase 3]
Phase 3 trial of maintenance Fluzoparib versus placebo in relapsed ovarian cancer has completed.
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation
A non-interventional prospective study evaluating first-line treatment approaches for HRD-positive ovarian cancer patients in the Russian Fe…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer [Phase 2]
Phase 2 study evaluating personalized timing of interval debulking surgery for advanced ovarian cancer. The trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial update describing a study on personalized timing of interval debulking surgery for advanced ovarian cancer; recruitment is ong…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer
Completed clinical trial from Institut Bergonié evaluating elderly patients' expectations and priorities for a first-line cancer treatment a…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer [Phase 1]
Phase 1 trial update on TAG72-CAR T cells for platinum-resistant epithelial ovarian cancer, with the study currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Short-term Fasting Compared to Free Diet on Ovarian Cancer Patients [NA]
A clinical trial update indicates a study is currently recruiting to compare short-term fasting with a free diet in patients with ovarian ca…
-
CLINICAL_TRIALS withdrawal · 2025-07-01Clinical Trial Update: A Study to Investigate LYL797 in Adults With Solid Tumors [Phase 1]
Lyell Immunopharma's Phase 1 study of LYL797 in adults with solid tumors has been terminated.